{"title":"伴有或不伴有轻微肺部变形的非纤维化(细胞性)超敏性肺炎。","authors":"Ryo Okuda , Tamiko Takemura , Toshihiro Misumi , Akimasa Sekine , Hideya Kitamura , Tomohisa Baba , Eri Hagiwara , Takashi Ogura","doi":"10.1016/j.resinv.2024.07.008","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>According to international diagnostic guidelines for hypersensitivity pneumonitis (HP), cases with both nonfibrotic and fibrotic lesions are classified by the predominant feature. Therefore, some cases with nonfibrotic HP, have inflammatory lesions alone, while others have a mixture of fibrosis and inflammation. We investigated the impact of slight fibrotic lesions in nonfibrotic HP.</p></div><div><h3>Methods</h3><p>This retrospective study included nonfibrotic HP cases with <10% of lung distortion on high-resolution CT. We divided the cases into two groups: those with pure ground glass opacities (GGOs) without lung distortion and those with slight lung distortion of <10%.</p></div><div><h3>Results</h3><p>In this study, 37 cases were included. The mean baseline forced vital capacity (FVC) was 109% in the pure GGO group and 96% in the slight lung distortion group (p = 0.038). After 1 year, the reticular shadows appeared or increased more in the slight lung distortion group than in the pure GGO group (16% vs. 8%, p = 0.030). The time to medication initiation was significantly shorter in the slight lung distortion group than in the pure GGO group (p = 0.044). %FVC decreased by ≥ 5% from diagnosis in no cases with the pure GGO and in two cases with the slight lung distortion (−11.0% for 9.5 years and −10.7% for 1.3 years, respectively).</p></div><div><h3>Conclusions</h3><p>The slight distortion group exhibited a higher rate of worsening and new appearance of reticular shadows after 1 year and a shorter time to first medication compared to the pure GGO group.</p></div>","PeriodicalId":20934,"journal":{"name":"Respiratory investigation","volume":"62 5","pages":"Pages 832-837"},"PeriodicalIF":2.4000,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Nonfibrotic (cellular) hypersensitivity pneumonitis with and without slight lung distortion\",\"authors\":\"Ryo Okuda , Tamiko Takemura , Toshihiro Misumi , Akimasa Sekine , Hideya Kitamura , Tomohisa Baba , Eri Hagiwara , Takashi Ogura\",\"doi\":\"10.1016/j.resinv.2024.07.008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>According to international diagnostic guidelines for hypersensitivity pneumonitis (HP), cases with both nonfibrotic and fibrotic lesions are classified by the predominant feature. Therefore, some cases with nonfibrotic HP, have inflammatory lesions alone, while others have a mixture of fibrosis and inflammation. We investigated the impact of slight fibrotic lesions in nonfibrotic HP.</p></div><div><h3>Methods</h3><p>This retrospective study included nonfibrotic HP cases with <10% of lung distortion on high-resolution CT. We divided the cases into two groups: those with pure ground glass opacities (GGOs) without lung distortion and those with slight lung distortion of <10%.</p></div><div><h3>Results</h3><p>In this study, 37 cases were included. The mean baseline forced vital capacity (FVC) was 109% in the pure GGO group and 96% in the slight lung distortion group (p = 0.038). After 1 year, the reticular shadows appeared or increased more in the slight lung distortion group than in the pure GGO group (16% vs. 8%, p = 0.030). The time to medication initiation was significantly shorter in the slight lung distortion group than in the pure GGO group (p = 0.044). %FVC decreased by ≥ 5% from diagnosis in no cases with the pure GGO and in two cases with the slight lung distortion (−11.0% for 9.5 years and −10.7% for 1.3 years, respectively).</p></div><div><h3>Conclusions</h3><p>The slight distortion group exhibited a higher rate of worsening and new appearance of reticular shadows after 1 year and a shorter time to first medication compared to the pure GGO group.</p></div>\",\"PeriodicalId\":20934,\"journal\":{\"name\":\"Respiratory investigation\",\"volume\":\"62 5\",\"pages\":\"Pages 832-837\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Respiratory investigation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2212534524001096\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory investigation","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212534524001096","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
摘要
背景:根据超敏性肺炎(HP)的国际诊断指南,具有非纤维化和纤维化病变的病例按主要特征分类。因此,一些非纤维化超敏性肺炎病例仅有炎症病变,而另一些病例则混合有纤维化和炎症。我们研究了非纤维化 HP 中轻微纤维化病变的影响:这项回顾性研究纳入了非纤维化 HP 病例:本研究共纳入 37 例病例。纯GGO组的平均基线用力肺活量(FVC)为109%,轻微肺扭曲组为96%(P = 0.038)。1 年后,轻微肺扭曲组的网状阴影出现或增加的比例高于纯 GGO 组(16% 对 8%,p = 0.030)。轻微肺扭曲组开始用药的时间明显短于纯 GGO 组(p = 0.044)。纯GGO组没有病例的FVC%比诊断时下降≥5%,而轻微肺扭曲组有两个病例的FVC%比诊断时下降≥5%(分别为9.5年-11.0%和1.3年-10.7%):结论:与纯GGO组相比,轻微变形组的病情恶化率和1年后新出现网状阴影的比率更高,首次用药时间更短。
Nonfibrotic (cellular) hypersensitivity pneumonitis with and without slight lung distortion
Background
According to international diagnostic guidelines for hypersensitivity pneumonitis (HP), cases with both nonfibrotic and fibrotic lesions are classified by the predominant feature. Therefore, some cases with nonfibrotic HP, have inflammatory lesions alone, while others have a mixture of fibrosis and inflammation. We investigated the impact of slight fibrotic lesions in nonfibrotic HP.
Methods
This retrospective study included nonfibrotic HP cases with <10% of lung distortion on high-resolution CT. We divided the cases into two groups: those with pure ground glass opacities (GGOs) without lung distortion and those with slight lung distortion of <10%.
Results
In this study, 37 cases were included. The mean baseline forced vital capacity (FVC) was 109% in the pure GGO group and 96% in the slight lung distortion group (p = 0.038). After 1 year, the reticular shadows appeared or increased more in the slight lung distortion group than in the pure GGO group (16% vs. 8%, p = 0.030). The time to medication initiation was significantly shorter in the slight lung distortion group than in the pure GGO group (p = 0.044). %FVC decreased by ≥ 5% from diagnosis in no cases with the pure GGO and in two cases with the slight lung distortion (−11.0% for 9.5 years and −10.7% for 1.3 years, respectively).
Conclusions
The slight distortion group exhibited a higher rate of worsening and new appearance of reticular shadows after 1 year and a shorter time to first medication compared to the pure GGO group.